Close

Dr Anna Schultze

Research Fellow
Pharmacoepidemiology - GSK Collaboration

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Anna is a pharmacoepidemiologist who joined the Electronic Health Records Group at LSHTM in 2020. Before joining LSHTM, Anna worked as a senior research associate at the consultancy firm Evidera, where she designed and managed post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. She completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also holds an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL. 

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

Anna teaches on Extended Epidemiology, Basic Epidemiology and on the Professional Certificate in Pharmacoepidemiology. 

Research

Anna is interested in how we can better use routinely collected data to study the effectiveness and safety of medications. Her current research uses self-controlled study designs to study COVID-19 vaccine safety, and explores how self-controlled studies can be applied to the analyses of clinical trial extension studies. She is also involved in a number of studies on the epidemiology of COVID-19 using the OpenSAFELY platform. 

Research Area
Pharmacovigilance
Primary care
Electronic health records
Methodology
Randomised controlled trials

Selected Publications

OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
Andrews C; Schultze A; Curtis H; Hulme W; Tazare J; Evans S; Mehrkar A; Bacon S; Hickman G; Bates C
2022
Wellcome Open Res
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England.
Andrews C; Schultze A; Curtis H; Hulme W; Tazare J; Evans S; Mehrkar A; Bacon S; Hickman G; Bates C
2022
Wellcome Open Research
OpenSAFELY: Representativeness of Electronic Health Record platform OpenSAFELY-TPP data compared to the population of England
Andrews C; Schultze A; Curtis H; Hulme W; Tazare J; Evans SJW; Mehrkhar A; Bacon S; Hickman G; Bates C
2022
medRxiv
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Hulme W; Williamson E; Horne E; Green A; Nab L; Keogh R; Parker EPK; Walker V; Palmer T; Curtis H
2022
medRxiv
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Hulme WJ; Williamson EJ; Green ACA; Bhaskaran K; McDonald HI; Rentsch CT; Schultze A; Tazare J; Curtis HJ; Walker AJ
2022
BMJ
Software development skills for health data researchers.
Morton C; Devito N; Morley J; Dillingham I; Schultze A; Bacon S; Inglesby P; Maude S; Goldacre B
2022
BMJ Health & Care Informatics
Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform
Wing K; Grint D; Mathur R; Gibbs H; Hickman G; Nightingale E; Schultze A; Forbes H; Nafilyan V; Bhaskaran K
2022
medRxiv
See more Publications